Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jim Klostergaard
New Agents for Taxol-Resistant Ovarian Carcinoma
Related publications
Synergistic Interaction Between Cisplatin and Taxol in Human Ovarian Carcinoma Cells in Vitro
British Journal of Cancer
Cancer Research
Oncology
Taxol-Resistant Epithelial Ovarian Tumors Are Associated With Altered Expression of Specific Beta-Tubulin Isotypes.
Journal of Clinical Investigation
Medicine
Leptin Contributes to the Taxol Chemoresistance in Epithelial Ovarian Cancer
Oncology Letters
Cancer Research
Oncology
New Agents on the Horizon in Hepatocellular Carcinoma
Therapeutic Advances in Medical Oncology
Oncology
Development of New Estrogen Receptor-Targeting Therapeutic Agents for Tamoxifen-Resistant Breast Cancer
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
Pegylated Liposomal Doxorubicin for Platinum-Resistant or Refractory M�llerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube and Peritoneal Carcinoma): A Single-Institutional Experience
Oncology Letters
Cancer Research
Oncology
High‐Dose Therapy for Ovarian Carcinoma
Oncologist
Cancer Research
Medicine
Oncology
Transcriptome-Based Signature Predicts the Effect of Taxol in Serous Ovarian Cancer
PLoS ONE
Multidisciplinary
Induction Chemotherapy With Carboplatin and Taxol Followed by Radiotherapy and Concurrent Weekly Carboplatin + Taxol in Locally Advanced Nasopharyngeal Carcinoma
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
